Taub Rebecca
Insider CIK 1423898 · MDGL See Remarks, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2026-06-17 | 2026-06-18 | 766 | — | $0 | 766 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2026-06-17 | 2026-06-18 | 454 | — | $0 | 452,667 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 491 | $431.94 | $212.1K | 452,213 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-26 | 2026-01-26 | 647 | $492.42 | $318.6K | 452,704 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-20 | 2026-01-20 | 2,238 | $490.77 | $1.10M | 453,351 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2026-01-09 | 2026-01-13 | 18,410 | — | $0 | 240 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2026-01-09 | 2026-01-13 | 240 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,135 | $526.95 | $598.1K | 458,858 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 913 | $526.05 | $480.3K | 459,993 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,489 | $525.12 | $781.9K | 460,906 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,335 | $524.06 | $699.6K | 462,395 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 732 | $522.98 | $382.8K | 463,730 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 588 | $521.95 | $306.9K | 464,462 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 440 | $521.11 | $229.3K | 465,050 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 539 | $519.89 | $280.2K | 465,490 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 970 | $518.67 | $503.1K | 466,029 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 2,044 | $517.84 | $1.06M | 466,999 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 521 | $516.81 | $269.3K | 469,043 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,578 | $515.82 | $814.0K | 469,564 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 937 | $514.63 | $482.2K | 471,142 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 960 | $513.12 | $492.6K | 472,079 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 960 | $512.02 | $491.5K | 473,039 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2026-01-09 | 2026-01-13 | 18,410 | $15.80 | $290.9K | 473,999 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 400 | $542.72 | $217.1K | 455,589 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 40 | $540.26 | $21.6K | 455,989 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 400 | $539.26 | $215.7K | 456,029 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 40 | $537.84 | $21.5K | 456,429 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 385 | $536.88 | $206.7K | 456,469 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 299 | $535.80 | $160.2K | 456,854 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 89 | $534.93 | $47.6K | 457,153 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 271 | $534.18 | $144.8K | 457,242 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 40 | $532.50 | $21.3K | 457,513 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 30 | $531.05 | $15.9K | 457,553 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 256 | $530.45 | $135.8K | 457,583 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 554 | $529.28 | $293.2K | 457,839 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 465 | $528.16 | $245.6K | 458,393 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 40 | $545.79 | $21.8K | 455,789 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2026-01-09 | 2026-01-13 | 240 | $15.80 | $3.8K | 455,829 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 200 | $551.24 | $110.2K | 455,589 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-12-10 | 2025-12-12 | 18,650 | — | $0 | 18,650 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 369 | $548.56 | $202.4K | 478,834 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-12-10 | 2025-12-12 | 18,650 | $15.80 | $294.7K | 479,694 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 491 | $547.76 | $269.0K | 479,203 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | G Gift | 2025-12-10 | 2025-12-12 | 5,455 | — | $0 | 455,589 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 486 | $550.07 | $267.3K | 478,348 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 4,723 | $550.99 | $2.60M | 473,625 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 200 | $555.39 | $111.1K | 461,044 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 1,027 | $554.84 | $569.8K | 461,244 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 3,087 | $553.88 | $1.71M | 462,271 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 3,857 | $552.81 | $2.13M | 465,358 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 4,410 | $551.85 | $2.43M | 469,215 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-08-12 | 2025-08-13 | 43,263 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 6,541 | $358.81 | $2.35M | 461,744 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 6,715 | $357.85 | $2.40M | 468,285 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 4,864 | $356.88 | $1.74M | 475,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 5,752 | $355.95 | $2.05M | 479,864 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 6,479 | $354.97 | $2.30M | 485,616 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 4,587 | $354.04 | $1.62M | 492,095 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 1,175 | $352.45 | $414.1K | 496,682 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 2,870 | $351.60 | $1.01M | 497,857 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 3,580 | $350.87 | $1.26M | 500,727 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-08-12 | 2025-08-13 | 43,263 | $9.45 | $408.8K | 504,307 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 700 | $359.71 | $251.8K | 461,044 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-08-11 | 2025-08-13 | 3,200 | — | $0 | 43,263 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-11 | 2025-08-13 | 220 | $351.02 | $77.2K | 461,044 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-11 | 2025-08-13 | 2,980 | $350.18 | $1.04M | 461,264 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-08-11 | 2025-08-13 | 3,200 | $9.45 | $30.2K | 464,244 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-07-18 | 2025-07-22 | 1,000 | — | $0 | 46,463 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-07-18 | 2025-07-22 | 1,000 | $9.45 | $9.4K | 462,044 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-18 | 2025-07-22 | 1,000 | $350.01 | $350.0K | 461,044 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-07-17 | 2025-07-18 | 2,657 | — | $0 | 47,463 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-17 | 2025-07-18 | 600 | $351.50 | $210.9K | 461,044 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-07-17 | 2025-07-18 | 2,657 | $9.45 | $25.1K | 463,701 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-17 | 2025-07-18 | 2,057 | $350.09 | $720.1K | 461,644 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-07-16 | 2025-07-18 | 26,444 | — | $0 | 50,120 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 1,380 | $356.52 | $492.0K | 461,044 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 6,441 | $355.61 | $2.29M | 462,424 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 5,800 | $354.61 | $2.06M | 468,865 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 2,569 | $353.82 | $909.0K | 474,665 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 1,897 | $351.37 | $666.5K | 479,591 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 6,000 | $350.19 | $2.10M | 481,488 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-07-16 | 2025-07-18 | 26,444 | $9.45 | $249.9K | 487,488 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 2,357 | $352.64 | $831.2K | 477,234 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2025-03-05 | 2025-03-07 | 7,381 | — | $0 | 7,381 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2025-03-05 | 2025-03-07 | 4,382 | — | $0 | 461,044 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-01-24 | 2025-01-27 | 648 | $335.24 | $217.2K | 456,662 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-01-17 | 2025-01-17 | 1,689 | $273.41 | $461.8K | 457,310 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-08 | 2024-04-10 | 2,676 | — | $0 | 76,564 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 200 | $248.58 | $49.7K | 458,999 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-08 | 2024-04-10 | 2,676 | $9.45 | $25.3K | 461,675 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 224 | $243.25 | $54.5K | 461,451 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 945 | $244.79 | $231.3K | 460,506 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 300 | $245.69 | $73.7K | 460,206 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 600 | $246.98 | $148.2K | 459,606 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 407 | $247.76 | $100.8K | 459,199 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-05 | 2024-04-05 | 27,506 | — | $0 | 79,240 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 700 | $241.14 | $168.8K | 484,162 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 8,817 | $242.61 | $2.14M | 475,345 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 8,989 | $243.33 | $2.19M | 466,356 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 2,079 | $244.45 | $508.2K | 464,277 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 5,278 | $245.53 | $1.30M | 458,999 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 1,643 | $240.11 | $394.5K | 484,862 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-05 | 2024-04-05 | 27,506 | $9.45 | $259.9K | 486,505 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-04 | 2024-04-05 | 18,537 | — | $0 | 106,746 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-04 | 2024-04-05 | 18,537 | $9.45 | $175.2K | 477,536 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 4,200 | $240.88 | $1.01M | 473,336 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 5,619 | $241.85 | $1.36M | 467,717 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 3,085 | $242.71 | $748.8K | 464,632 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 435 | $244.01 | $106.1K | 464,197 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 2,734 | $245.06 | $670.0K | 461,463 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 1,653 | $246.01 | $406.7K | 459,810 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 711 | $247.23 | $175.8K | 459,099 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 100 | $248.23 | $24.8K | 458,999 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-03 | 2024-04-05 | 27,845 | — | $0 | 125,283 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-03 | 2024-04-05 | 27,845 | $9.45 | $263.1K | 486,844 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 135 | $242.00 | $32.7K | 486,709 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 2,634 | $243.68 | $641.9K | 484,075 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 4,070 | $244.68 | $995.8K | 480,005 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 18,917 | $245.34 | $4.64M | 461,088 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 2,089 | $246.32 | $514.6K | 458,999 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-01-23 | 2024-01-25 | 8,718 | — | $0 | 8,718 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-01-23 | 2024-01-25 | 5,786 | — | $0 | 5,786 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2024-01-23 | 2024-01-25 | 5,786 | — | $0 | 20,787 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | F Tax w/h | 2024-01-16 | 2024-01-18 | 1,546 | $243.92 | $377.1K | 15,001 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2023-01-16 | 2023-01-18 | 20,001 | — | $0 | 20,001 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2022-02-22 | 2022-02-24 | 61,500 | — | $0 | 61,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2021-02-22 | 2021-02-23 | 44,000 | — | $0 | 44,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2020-03-05 | 2020-03-05 | 44,000 | — | $0 | 44,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2019-07-10 | 2019-07-11 | 8,000 | — | $0 | 8,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2019-03-07 | 2019-03-11 | 38,000 | — | $0 | 38,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2018-06-11 | 2018-06-12 | 73,526 | $287.46 | $21.14M | 655,540 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2018-03-01 | 2018-03-05 | 38,000 | — | $0 | 38,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2017-03-02 | 2017-03-06 | 37,300 | — | $0 | 37,300 | SEC↗ |
| MDGL SYNTA PHARMACEUTICALS CORP | A Award deriv | 2016-07-22 | 2016-07-26 | 143,557 | — | $0 | 143,557 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2016-07-22 | 2016-08-23 | 153,128 | — | $0 | 153,128 | SEC↗ |
| MDGL SYNTA PHARMACEUTICALS CORP | A Award | 2016-07-22 | 2016-07-26 | 28,740 | — | $0 | 432,872 | SEC↗ |
| MDGL SYNTA PHARMACEUTICALS CORP | A Award | 2016-07-22 | 2016-07-26 | 404,132 | — | $0 | 404,132 | SEC↗ |
| MDGL SYNTA PHARMACEUTICALS CORP | A Award | 2016-07-22 | 2016-07-26 | 729,066 | — | $0 | 729,066 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2016-07-22 | 2016-08-23 | 30,626 | — | $0 | 434,758 | SEC↗ |